New pill tested for Tough-to-Treat cancers
NCT ID NCT07253116
Summary
This early-stage study is testing a new oral tablet called WJ22096 in patients with advanced solid tumors, like lung, colorectal, and pancreatic cancer, who have no other standard treatment options. The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it might help control the cancer. The study will start by testing different doses in a small group and then expand to see how well it works in specific cancer types.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.